Lexaria CEO Chris Bunka on the Latest Cannabinoid Patents With Big Potential Revenue Streams
2,187 views · Published 2 February 2018 · 6:54 · Indexed 3 October 2026
Channel: Midas Letter · 2018 · Education
Lexaria Bioscience Corp (CNSX:LXX) (OTCMKTS:LXRP) is a drug delivery platform innovator. CEO Chris Bunka talks about the company's new patent which covers new cannabinoids and other ingestible molecules delivery platform, as well as its DehydraTECH™ technology, which improves tastes and the rapidity in which a drug reaches your blood stream. The nicotine space is seen as one of the biggest opportunities for Lexaria products. ************************ LINK: http://bit.ly/LexariaPatent ************************ Check out our website: https://MidasLetter.com ************************ SUBSCRIBE to our YouTube: http://bit.ly/MidasLetterYoutube SUBSCRIBE to our Newsletter: http://bit.ly/MidasLetterNewsletter Download Our Podcast on iTunes: http://bit.ly/MidasLetterPodcast ************************ Follow Us on Twitter: http://bit.ly/MidasLetterTwitter Like Us on Instagram: http://bit.ly/MidasLetterInsta Like Us on Facebook: http://bit.ly/MidasLetterFacebook ************************
More from this channel
-
6:42
GreenBank CEO Danny Wettreich on Investing in Ubique and Blockchain Evolution
-
7:50
Paycase Financial CEO Joseph Weinberg on Bitcoin Technology for Overseas Transactions
-
6:13
NeutriSci is into Energy Tablets, THC, and Genie Bouchard!
-
7:45
Current Water Technologies is Using Their Patents to Clean Public Water Around the World
-
2:50
American Pacific Mining High-Grade Gold Exploration in Nevada
-
9:36
Aereus Technologies Prevents Spread of Infections with Copper Thermal Coating, Microbial Tech
-
6:12
Investor Derek Sinclair on Cryptocurrency Opportunities
-
7:16
LiveWell Foods (CVE:LVWL) CEO Seann Poli on Cannabis Bioceuticals